Domenico Di Marzo
Naples, 80131, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Correction: P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma.
Journal: Cell death & disease
Published: June 11, 2026
Correction: P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma.
Journal: Cell death & disease
Published: October 17, 2020
P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma.
Journal: Cell death & disease
Published: March 06, 2020
Targeted therapy based on p53 reactivation reduces both glioblastoma cell growth and resistance to temozolomide.
Journal: International journal of oncology
Published: August 09, 2018
Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem Cells.
Journal: Journal of cellular physiology
Published: July 24, 2015
pRb2/p130 localizes to the cytoplasm in diffuse gastric cancer.
Journal: Journal of cellular physiology
Published: August 22, 2014
SRC family kinase (SFK) inhibition reduces rhabdomyosarcoma cell growth in vitro and in vivo and triggers p38 MAP kinase-mediated differentiation.
Journal: Oncotarget
Published: August 01, 2014
MicroRNA-29b-1 impairs in vitro cell proliferation, self‑renewal and chemoresistance of human osteosarcoma 3AB-OS cancer stem cells.
Journal: International journal of oncology
Published: April 23, 2014
Antineoplastic activity of povidone-iodine on different mesothelioma cell lines: results of in vitro study.
Journal: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
Published: January 08, 2014
Abrogating G₂/M checkpoint through WEE1 inhibition in combination with chemotherapy as a promising therapeutic approach for mesothelioma.
Journal: Cancer biology & therapy
Published: December 25, 2013
Pharmacological targeting of p53 through RITA is an effective antitumoral strategy for malignant pleural mesothelioma.
Journal: Cell cycle (Georgetown, Tex.)
Published: December 19, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026